"/> Novus Biologicals™ Peptide bloquant d’anticorps BA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BASC4

Réf. : BL-RE-054672Réf. fabricant : 18259445 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
55653
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77126. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 14 amino acids near the amino terminus of human BCAS4.

Points forts

Source

Synthetic

(Accession #: CAI23006) The BASC4 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-054672
Réf. fabricant18259445
Gene ID (Entrez)55653
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77126. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneBCAS4/BCAS3 fusion, breast carcinoma amplified sequence 4, breast carcinoma amplified sequence 4/3 fusion protein, breast carcinoma-amplified sequence 4, CNOL, FLJ20495
Symbole de gène(s)BCAS4
Type de produitBASC4
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne14 amino acids near the amino terminus of human BCAS4
Une question, une configuration particulière ?
Contactez-nous pour un devis.